Literature DB >> 26577295

Incidence of lymph node metastasis in intramucosal gastric cancer measuring 30 mm or less, with ulceration; mixed, predominantly differentiated-type histology; and no lymphovascular invasion: a multicenter retrospective study.

Kohei Takizawa1, Hiroyuki Ono2, Yorimasa Yamamoto3, Hitoshi Katai4, Shinichiro Hori5, Tomonori Yano6, Eiji Umegaki7, Shunya Sasaki8, Toshiro Iizuka9, Kei Kawagoe10, Tadakazu Shimoda11, Manabu Muto12, Mitsuru Sasako13.   

Abstract

BACKGROUND: Intramucosal gastric cancer, ≤3 cm (≤30 mm) with ulceration, and mixed histology (predominantly differentiated), was previously considered curative after endoscopic resection, and additional surgery was thought to be unnecessary. However, as the evidence base for these criteria remains insufficient, the Japanese Gastric Cancer Treatment Guidelines, ver. 3 (2010) specify that this pathology should be considered noncurative and recommend additional surgery. We report the frequency of lymph node metastasis in patients with these conditions based on a multicenter study.
METHODS: Of patients with early gastric cancer who underwent gastrectomy with lymph node dissection, those with a mixed, predominantly differentiated tumor type, ulceration, a tumor diameter ≤3 cm, and no lymphovascular invasion were entered into this study.
RESULTS: Four hundred and seven patients met the criteria, 21 of whom were excluded owing to a lack of available information. Thus, a total of 386 patients were included in the analysis, from 37 of the 42 member institutions. The mean study duration was 125 months. The most common combination of mixed histology was tub2 + por (67 %). None of the 386 patients had lymph node metastasis (95 % confidence interval, 0-0.8 %).
CONCLUSION: The results of this retrospective study indicate that the risk of lymph node metastasis was less than 1 % among patients with the criteria defined here, considered to be criteria for noncurative resection as per the current guidelines, and suggest that observation alone without additional surgery may result in a good outcome.

Entities:  

Keywords:  Additional indication; Early gastric cancer; Endoscopic submucosal dissection; Mixed histology; Undifferentiated adenocarcinoma

Mesh:

Year:  2015        PMID: 26577295     DOI: 10.1007/s10120-015-0569-x

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  7 in total

1.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

2.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Endoscopic mucosal resection for treatment of early gastric cancer.

Authors:  H Ono; H Kondo; T Gotoda; K Shirao; H Yamaguchi; D Saito; K Hosokawa; T Shimoda; S Yoshida
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.

Authors:  Takuji Gotoda; Akio Yanagisawa; Mitsuru Sasako; Hiroyuki Ono; Yukihiro Nakanishi; Tadakazu Shimoda; Yo Kato
Journal:  Gastric Cancer       Date:  2000-12       Impact factor: 7.370

5.  A phase II clinical trial of endoscopic submucosal dissection for early gastric cancer of undifferentiated type: Japan Clinical Oncology Group study JCOG1009/1010.

Authors:  Kohei Takizawa; Atsuo Takashima; Aya Kimura; Junki Mizusawa; Noriaki Hasuike; Hiroyuki Ono; Masanori Terashima; Manabu Muto; Narikazu Boku; Mitsuru Sasako; Haruhiko Fukuda
Journal:  Jpn J Clin Oncol       Date:  2012-11-19       Impact factor: 3.019

6.  A phase II trial of endoscopic submucosal dissection for mucosal gastric cancer: Japan Clinical Oncology Group Study JCOG0607.

Authors:  Yukinori Kurokawa; Noriaki Hasuike; Hiroyuki Ono; Narikazu Boku; Haruhiko Fukuda
Journal:  Jpn J Clin Oncol       Date:  2009-06-03       Impact factor: 3.019

7.  Risk of lymph node metastases from intramucosal gastric cancer in relation to histological types: how to manage the mixed histological type for endoscopic submucosal dissection.

Authors:  Kohei Takizawa; Hiroyuki Ono; Naomi Kakushima; Masaki Tanaka; Noriaki Hasuike; Hiroyuki Matsubayashi; Yuichiro Yamagichi; Etsuro Bando; Masanori Terashima; Kimihide Kusafuka; Takashi Nakajima
Journal:  Gastric Cancer       Date:  2012-11-29       Impact factor: 7.370

  7 in total
  13 in total

1.  Comparative study between endoscopic submucosal dissection and surgery in patients with early gastric cancer.

Authors:  Kyu Yeon Hahn; Chan Hyuk Park; Yong Kang Lee; Hyunsoo Chung; Jun Chul Park; Sung Kwan Shin; Yong Chan Lee; Hyoung-Il Kim; Jae-Ho Cheong; Woo Jin Hyung; Sung Hoon Noh; Sang Kil Lee
Journal:  Surg Endosc       Date:  2017-06-21       Impact factor: 4.584

2.  Histological Differentiated/Undifferentiated Mixed Type Should Not Be Considered as a Non-Curative Factor of Endoscopic Resection for Patients With Early Gastric Cancer.

Authors:  Xiaolong Tang; Mengjun Zhang; Qingsi He; Guorui Sun; Chao Wang; Peng Gao; Hui Qu
Journal:  Front Oncol       Date:  2020-09-03       Impact factor: 6.244

3.  A case of mixed-type early gastric cancer with recurrence following curative endoscopic submucosal dissection for expanded indication.

Authors:  Shunsuke Kobayashi; Satoru Nonaka; Ichiro Oda; Seiichiro Abe; Haruhisa Suzuki; Shigetaka Yoshinaga; Hirokazu Taniguchi; Shigeki Sekine; Yoshinori Igarashi; Yutaka Saito
Journal:  Endosc Int Open       Date:  2019-06-12

4.  Prognostic significance of lymphovascular infiltration in overall survival of gastric cancer patients after surgery with curative intent.

Authors:  Liangliang Wu; Yuexiang Liang; Chen Zhang; Xiaona Wang; Xuewei Ding; Chongbiao Huang; Han Liang
Journal:  Chin J Cancer Res       Date:  2019-10       Impact factor: 5.087

5.  PD-L1 Expression Level Displays a Positive Correlation with Immune Response in Pancreatic Cancer.

Authors:  Lei Zhao; Yaming Cao
Journal:  Dis Markers       Date:  2020-09-25       Impact factor: 3.434

6.  Favorable Long-Term Outcomes of Endoscopic Submucosal Dissection for Differentiated-Type-Predominant Early Gastric Cancer with Histological Heterogeneity.

Authors:  Tae-Se Kim; Hyeong Chan Shin; Byung-Hoon Min; Kyoung-Mee Kim; Yang Won Min; Hyuk Lee; Jun Haeng Lee; Poong-Lyul Rhee; Jae J Kim
Journal:  J Clin Med       Date:  2020-04-09       Impact factor: 4.241

7.  Identification of molecular biomarkers for the diagnosis of gastric cancer and lymph-node metastasis.

Authors:  Sharvesh Raj Seeruttun; Wing Yan Cheung; Wei Wang; Cheng Fang; Zhi-Min Liu; Jin-Qing Li; Ting Wu; Jun Wang; Chun Liang; Zhi-Wei Zhou
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-08-13

8.  Development and validation of a nomogram for preoperative prediction of lymph node metastasis in early gastric cancer.

Authors:  Xiao-Yi Yin; Tao Pang; Yu Liu; Hang-Tian Cui; Tian-Hang Luo; Zheng-Mao Lu; Xu-Chao Xue; Guo-En Fang
Journal:  World J Surg Oncol       Date:  2020-01-02       Impact factor: 2.754

9.  Histopathological validation of magnifying endoscopy for diagnosis of mixed-histological-type early gastric cancer.

Authors:  Yuichiro Ozeki; Kingo Hirasawa; Ryosuke Kobayashi; Chiko Sato; Yoko Tateishi; Atsushi Sawada; Ryosuke Ikeda; Masafumi Nishio; Takehide Fukuchi; Makomo Makazu; Masataka Taguri; Shin Maeda
Journal:  World J Gastroenterol       Date:  2020-09-28       Impact factor: 5.742

10.  Risk of Lymph Node Metastasis and Feasibility of Endoscopic Treatment in Ulcerative Early Gastric Cancer.

Authors:  Ming-Han Ren; Xing-Si Qi; Yu-Ning Chu; Ya-Nan Yu; Yun-Qing Chen; Peng Zhang; Tao Mao; Zi-Bin Tian
Journal:  Ann Surg Oncol       Date:  2020-09-25       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.